Pulmonology

A recent analysis that included data on 284 patients found that more than 80% of patients with resistant hypertension also had obstructive sleep apnea.

The biologic becomes the first in its drug class to be indicated for patients aged 6-11 years old with the difficult-to-treat condition.

Obstructive sleep apnea has been consistently underdiagnosed in US populations. Are screening methods enough?

Addressing the drivers of poor sleep conditions is among the many ways a physician can treat patients without prescription.

How a pattern of poor sleep could begin a cycle of worsened respiratory and cardiovascular health.

Dr. Rizzo provides a look into the current methods of COPD screening, and how patient treatment potential is changed.

The approval for interstitial lung disease associated with systemic sclerosis or scleroderma makes nintedanib the first therapy for the rare condition.

A new extended trial for the liquid immunotherapy shows two-thirds of allergic children were able to consume at least 750 mg of peanut after 3-5 years.

Particle-depleted diesel exhaust may impair a person's lung function worse than just standard diesel exhaust—while also exposing them to more NO2.

How do at-risk exacerbation patients present, and what developing therapies could benefit them?

Air pollution is driving pediatric risk for lung disease. Are there therapies at hand to address it?

Investigative triple therapy PT010 from AstraZeneca has reached primary outcome results versus a pair of standard dual inhaled therapies.

CDC data show the infectious respiratory disease has been on a decline since at least 2007—though measures are still needed to address its prevalence in certain populations.

A study comparing the LABA agent to maintenance therapy showed results supporting recent GINA recommendations for mild asthma management.

What is the large-scale study looking to bring to clinical respiratory health understanding?

In what ways do the respiratory conditions differentiate in progression and care options?

A 600-city analysis of particulate matter found daily exposure is linked to worsened mortality rates, particularly in areas with higher mean temperatures.

Investigators from the University of Pennsylvania found that negative effects of vaping on blood vessels can be noted after a single use.

Clinicians have indicated which symptom subtypes are associated with a greater risk of cardiovascular conditions in patients with OSA.

In a population-based cohort study, investigators discover how allergy immunotherapy helps allergic rhinitis from progressing to asthma.

The August 14 approval marks the second drug approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs.

The first longitudinal study to assess air pollution and emphysema progression provides novel long-term findings.

How do the states with the longest-running legislation permitting MAID compare?

OSA patients with certain traits experienced a 73% reduction in AHI events from oral appliance treatment.

New phase 3 data will evidence an FDA application for the biologic as an add-on therapy for patients aged 6-11 years with AD.